Association between NMR metabolomic signatures of healthy lifestyle and incident coronary artery disease. 2023

Zuqiang Fu, and Qian Liu, and Jingjia Liang, and Zhenkun Weng, and Wenxiang Li, and Jin Xu, and Xin Zhang, and Cheng Xu, and Aihua Gu
State Key Laboratory of Reproductive Medicine, School of Public Health, Nanjing Medical University, 101 Longmian Avenue, Nanjing 211166, China.

To identify metabolites associated with a healthy lifestyle and explore the possible mechanisms of lifestyle in coronary artery disease (CAD). The nuclear magnetic resonance metabolomics platform was applied to perform metabolomic profiling of baseline plasma samples from a randomly selected subset of 121 733 UK Biobank participants. Cox proportional hazards models with covariate adjustments were used to investigate the associations between validated lifestyle-associated metabolites and incident CAD and to estimate the accuracy of the inclusion of metabolites to predict CAD compared with traditional prediction models. The discriminatory ability of each model was evaluated using Harrell's C statistic, integrated discrimination improvement (IDI), and continuous net reclassification improvement (NRI) indexes. During a median of 8.6 years of follow-up, 5513 incident CAD cases were documented. Among the 111 lifestyle-associated metabolites, 65 were significantly associated with incident CAD after multivariate adjustment (Bonferroni P < 3.11 × 10-04). The addition of these metabolites to classic risk prediction models [Framingham Risk Score (FRS) using lipids; FRS using body mass index] improved CAD prediction accuracy as assessed by the C statistic (increasing to 0.739 [95% CI, 0.731-0.747] and 0.752 [95% CI, 0.746-0.758]), respectively; continuous NRI (0.274 [0.227-0.325] and 0.266 [0.223-0.317]) and IDI (0.003 [0.002-0.004] and 0.003 [0.002-0.004]). Healthy lifestyle-associated metabolites are associated with the incidence of CAD and may help improve the prediction of CAD risk. The use of metabolite information combined with the FRS model warrants further investigation before clinical implementation.

UI MeSH Term Description Entries
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D003324 Coronary Artery Disease Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause. Arteriosclerosis, Coronary,Atherosclerosis, Coronary,Coronary Arteriosclerosis,Coronary Atherosclerosis,Left Main Coronary Artery Disease,Left Main Coronary Disease,Left Main Disease,Arterioscleroses, Coronary,Artery Disease, Coronary,Artery Diseases, Coronary,Atheroscleroses, Coronary,Coronary Arterioscleroses,Coronary Artery Diseases,Coronary Atheroscleroses,Left Main Diseases
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000070497 Healthy Lifestyle A pattern of behavior involving LIFE STYLE choices which ensure optimum health. Examples are eating right; maintaining physical, emotional, and spiritual wellness, and taking preemptive steps against communicable diseases. Healthy Life Style,Healthy Life Styles,Healthy Lifestyles,Life Style, Healthy,Life Styles, Healthy,Lifestyle, Healthy,Lifestyles, Healthy
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D055432 Metabolomics The systematic identification and quantitation of all the metabolic products of a cell, tissue, organ, or organism under varying conditions. The METABOLOME of a cell or organism is a dynamic collection of metabolites which represent its net response to current conditions. Metabonomics,Metabolomic,Metabonomic
D018570 Risk Assessment The qualitative or quantitative estimation of the likelihood of adverse effects that may result from exposure to specified health hazards or from the absence of beneficial influences. (Last, Dictionary of Epidemiology, 1988) Assessment, Risk,Benefit-Risk Assessment,Risk Analysis,Risk-Benefit Assessment,Health Risk Assessment,Risks and Benefits,Analysis, Risk,Assessment, Benefit-Risk,Assessment, Health Risk,Assessment, Risk-Benefit,Benefit Risk Assessment,Benefit-Risk Assessments,Benefits and Risks,Health Risk Assessments,Risk Analyses,Risk Assessment, Health,Risk Assessments,Risk Benefit Assessment,Risk-Benefit Assessments

Related Publications

Zuqiang Fu, and Qian Liu, and Jingjia Liang, and Zhenkun Weng, and Wenxiang Li, and Jin Xu, and Xin Zhang, and Cheng Xu, and Aihua Gu
May 2024, The American journal of medicine,
Zuqiang Fu, and Qian Liu, and Jingjia Liang, and Zhenkun Weng, and Wenxiang Li, and Jin Xu, and Xin Zhang, and Cheng Xu, and Aihua Gu
March 2023, Clinical epigenetics,
Zuqiang Fu, and Qian Liu, and Jingjia Liang, and Zhenkun Weng, and Wenxiang Li, and Jin Xu, and Xin Zhang, and Cheng Xu, and Aihua Gu
July 2019, Arteriosclerosis, thrombosis, and vascular biology,
Zuqiang Fu, and Qian Liu, and Jingjia Liang, and Zhenkun Weng, and Wenxiang Li, and Jin Xu, and Xin Zhang, and Cheng Xu, and Aihua Gu
September 2010, The American journal of cardiology,
Zuqiang Fu, and Qian Liu, and Jingjia Liang, and Zhenkun Weng, and Wenxiang Li, and Jin Xu, and Xin Zhang, and Cheng Xu, and Aihua Gu
March 2022, JAMA network open,
Zuqiang Fu, and Qian Liu, and Jingjia Liang, and Zhenkun Weng, and Wenxiang Li, and Jin Xu, and Xin Zhang, and Cheng Xu, and Aihua Gu
October 2022, Scientific reports,
Zuqiang Fu, and Qian Liu, and Jingjia Liang, and Zhenkun Weng, and Wenxiang Li, and Jin Xu, and Xin Zhang, and Cheng Xu, and Aihua Gu
July 2022, The American journal of clinical nutrition,
Zuqiang Fu, and Qian Liu, and Jingjia Liang, and Zhenkun Weng, and Wenxiang Li, and Jin Xu, and Xin Zhang, and Cheng Xu, and Aihua Gu
January 2024, European journal of clinical investigation,
Zuqiang Fu, and Qian Liu, and Jingjia Liang, and Zhenkun Weng, and Wenxiang Li, and Jin Xu, and Xin Zhang, and Cheng Xu, and Aihua Gu
October 2021, Clinical epigenetics,
Zuqiang Fu, and Qian Liu, and Jingjia Liang, and Zhenkun Weng, and Wenxiang Li, and Jin Xu, and Xin Zhang, and Cheng Xu, and Aihua Gu
February 2023, Preventive medicine,
Copied contents to your clipboard!